Safai B, Bason M, Friedman-Birnbaum R, Nisce L
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
J Invest Dermatol. 1990 Dec;95(6 Suppl):166S-169S. doi: 10.1111/1523-1747.ep12875222.
This report is intended to summarize the use of Interferon in the treatment of Kaposi's sarcoma (KS) associated with AIDS. The review is basically focused on the trials in the United States, which resulted in approval by the Food & Drug Administration (FDA) of the use of recombinant interferon alpha for the treatment of Kaposi's sarcoma.
本报告旨在总结干扰素在治疗与艾滋病相关的卡波西肉瘤（KS）中的应用。该综述主要聚焦于美国的试验，这些试验促使美国食品药品监督管理局（FDA）批准使用重组干扰素α治疗卡波西肉瘤。
